Zoetis Inc. SEC filings ZTS

Zoetis Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Feb 19, 2020. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Zoetis Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Aug 12, 2025 —
FWP Free writing prospectus Aug 11, 2025 —
424B3 Prospectus Aug 11, 2025 —
S-3ASR Automatic shelf registration Aug 5, 2025 —
424B2 Prospectus Nov 10, 2022 —
FWP Free writing prospectus Nov 8, 2022 —
424B3 Prospectus Nov 8, 2022 —
S-8 Employee stock plan registration Aug 5, 2022 —
S-3ASR Automatic shelf registration Aug 5, 2022 —
424B2 Prospectus May 11, 2020 —
FWP Free writing prospectus May 7, 2020 —
424B3 Prospectus May 7, 2020 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ZTS (NYSE)
Fiscal year ends
December 31
Headquarters
Parsippany, NJ
SEC filer status
Large accelerated filer
SEC CIK
1555280

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.